4.7 Article

Comparative analysis of the immune response to RFA and cryoablation in a colon cancer mouse model

Journal

SCIENTIFIC REPORTS
Volume 12, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41598-022-22279-w

Keywords

-

Funding

  1. National Institutes of Health (NIH)
  2. National Institutes of Health (NIH) [NIH Z01 1ZID BC011242, CL040015]
  3. Biocompatibles UK Ltd-Boston Scientific Corporation
  4. Clinical Translational Fellowship Program of the NIH Clinical Center
  5. Intramural Research Program of the National Institute of Biomedical Imaging and Bioengineering

Ask authors/readers for more resources

The immune responses to radiofrequency ablation (RFA) and cryoablation (CRA) were characterized and compared in a mouse model of colon cancer. The study found that both RFA and CRA induced cell death, reduced systemic T-regulatory cells and myeloid-derived suppressor cells, and affected cytokine secretion. However, RFA demonstrated more pronounced anti-tumoral immunity in the tumor microenvironment, while CRA induced a wider array of cytokine secretion.
The immune response to radiofrequency ablation (RFA) and cryoablation (CRA) was characterized and compared in a colon cancer mouse model. All studies were conducted under a research protocol approved by the National Institutes of Health, Clinical Center, Animal Care and Use Committee. BALB/cJ mice were inoculated with CT26 cells, and randomized to RFA, CRA, or sham treatment. Mice were sacrificed 3 days post-treatment, and tumor, spleen, and serum were harvested. Cell death was determined by Caspase-3 immunohistochemical and TUNEL stains. Immune response was analyzed using flow cytometry, serum cytokine assay and immunohistochemistry. Cell death, necrosis, and apoptosis induced by ablation were comparable in RFA and CRA. Decreased frequency of systemic T-regulatory cells was found in the CRA group. Both RFA and CRA reduced frequencies of several myeloid-derived suppressor cell (MDSC) subpopulations. RFA induced pro-inflammatory cytokine secretion including TNF-alpha and IL-12 as well as anti-inflammatory cytokines IL-5, and IL-10. CRA augmented secretion of a wider array of cytokines compared to RFA with both pro- and anti-inflammatory properties including IL-1 beta, IL-5, IL-6, IL-10, and KC GRO. In the tumor microenvironment, RFA reduced the number of T-regulatory cells, a finding not observed with CRA. Reduction of immune suppression via decreases in T-regulatory cells and MDSC was found to be induced by RFA or CRA. CRA augmented a wider range of cytokines than RFA, which were mainly pro-inflammatory, but also anti-inflammatory. In the tumor microenvironment, RFA demonstrated more pronounced anti-tumoral immunity. Further delineation of specific immunomodulation induced by ablation could inform drug-device development and may play a role in future hypothesis-driven immunomodulatory paradigms that combine immunotherapy drugs with tumor destruction for the treatment of metastatic colon cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available